{"id":654394,"date":"2026-08-24T20:09:22","date_gmt":"2026-08-24T20:09:22","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/654394\/"},"modified":"2026-08-24T20:09:22","modified_gmt":"2026-08-24T20:09:22","slug":"common-energy-boosting-supplements-may-help-pancreatic-cancer-cells-survive-chemo","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/654394\/","title":{"rendered":"Common energy-boosting supplements may help pancreatic cancer cells survive chemo"},"content":{"rendered":"<p>    <a href=\"https:\/\/www.foxnews.com\/video\/6401902629112\" data-omtr-intcmp=\"fnc_health_article_main-content_featured-video_5_1\" data-v-7b1896ea=\"\" rel=\"nofollow noopener\" target=\"_blank\">Pancreatic cancer vaccine shows promise in first human trial<\/a> <\/p>\n<p data-v-7b1896ea=\"\">Family medicine physician Dr. Jessica Gray details a new experimental pancreatic cancer vaccine showing promise in its first human trial. The vaccine, targeting the KRAS mutation, generated an immune response in 90% of high-risk patients. Dr. Gray discusses the 5-7 year timeline for public availability and emphasizes why pancreatic cancer is so deadly, highlighting advances in cancer treatments.<\/p>\n<p>NEWYou can now listen to Fox News articles!\n  <\/p>\n<p data-layout-index=\"5\" class=\"speakable\">Over-the-counter anti-aging supplements taken by millions of Americans to boost energy and lessen the side effects of chemotherapy may actually impair <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552553\" href=\"https:\/\/www.foxnews.com\/category\/health\/health-care\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">cancer treatments<\/a>, a new study suggests.<\/p>\n<p data-layout-index=\"5\" class=\"speakable\">Researchers at the Case Western Reserve University School of Medicine found that popular vitamin B3 derivatives \u2013 including nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide (NAM) \u2013 could help <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552554\" href=\"https:\/\/www.foxnews.com\/category\/health\/cancer\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">cancer cells<\/a> survive chemotherapy.<\/p>\n<p data-layout-index=\"5\">Those compounds are used by the body to produce NAD+, a molecule that helps cells generate energy and repair damage.<\/p>\n<p data-layout-index=\"5\"><a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552555\" href=\"https:\/\/www.foxnews.com\/health\/iv-therapy-supplements-scrutiny-experts-warn-potential-side-effects\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>IV THERAPY AND SUPPLEMENTS UNDER SCRUTINY AS EXPERTS WARN OF POTENTIAL SIDE EFFECTS<\/strong><\/a><\/p>\n<p data-layout-index=\"5\">The study, published in the journal Cancer Letters, examined how these supplements interact with treatments for <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552556\" href=\"https:\/\/www.foxnews.com\/health\/new-pancreatic-cancer-pill-could-reshape-treatment-early-trial-results-stun-researchers\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">pancreatic cancer<\/a>, a particularly deadly form of the disease with a 13% five-year survival rate, according to the American Cancer Society.<\/p>\n<p> <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/08\/woman-shopping-for-vitamins.jpg\" alt=\"Woman shopping for vitamins\" width=\"1200\" height=\"675\"\/> <\/p>\n<p>Over-the-counter vitamin B3 derivatives, specifically NMN, NR and NAM, could help pancreatic cancer cells survive chemotherapy treatment, the study suggests. (iStock)<\/p>\n<p data-layout-index=\"5\">While boosting NAD+ levels through dietary supplements can offer <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552557\" href=\"https:\/\/www.foxnews.com\/health\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">health benefits<\/a> to non-cancerous cells, pancreatic cancer cells may exploit the extra resources to repair damage caused by chemotherapy and avoid cell death, the researchers found.<\/p>\n<p data-layout-index=\"5\">In both laboratory settings and animal models, the supplements shielded cancer cells against three common chemotherapy drugs: oxaliplatin, 5-fluorouracil and gemcitabine. As a result, tumors survived chemotherapy doses that typically would prove fatal to them.<\/p>\n<p data-layout-index=\"5\"><a href=\"https:\/\/www.foxnews.com\/newsletters?cmpid=fnfirstnl\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER<\/strong><\/a><\/p>\n<p data-layout-index=\"5\">&#8220;Our findings highlight a potentially concerning role for NAD+-boosting supplements in the context of active cancer, especially when used in conjunction with chemotherapy,&#8221; said study lead Jordan Winter, a professor at Case Western Reserve School of Medicine and co-leader of the developmental therapeutics program at the Case Comprehensive Cancer Center, in the press release.<\/p>\n<p data-layout-index=\"5\"><a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552559\" href=\"http:\/\/www.foxnews.com\/health\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>CLICK HERE FOR MORE HEALTH STORIES<\/strong><\/a><\/p>\n<p data-layout-index=\"5\">&#8220;Our discovery is a call to action for the medical community.&#8221;<\/p>\n<p data-layout-index=\"5\">The study notes that these B3 derivatives are not considered dangerous for healthy individuals using them for general wellness. However, the risk becomes significant for patients currently undergoing active <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552560\" href=\"https:\/\/www.foxnews.com\/category\/health\/cancer\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">cancer therapy<\/a>.<\/p>\n<p> <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/08\/istock-1467893187.jpg\" alt=\"pancreatic cancer 3D rendering\" width=\"1200\" height=\"675\"\/> <\/p>\n<p>Boosting NAD+ levels provides extra energy to cancer cells, allowing them to repair DNA damage caused by chemotherapy. (iStock)<\/p>\n<p data-layout-index=\"5\">&#8220;This research is a critical reminder that \u2018natural\u2019 doesn\u2019t always mean safe, especially in the complex biology of cancer treatment,&#8221; Winter added.<\/p>\n<p data-layout-index=\"5\">In light of the findings, the research team recommends that oncology teams begin routinely screening patients for supplement use. They also called for more studies into how NAD+ precursors interact with cancer therapies.<\/p>\n<p data-layout-index=\"5\"><a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552561\" href=\"https:\/\/www.foxnews.com\/category\/lifestyle\/quizzes\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ<\/strong><\/a><\/p>\n<p data-layout-index=\"5\">Winter urged patients currently in treatment to consult their oncologists before taking any <a data-omtr-intcmp=\"fnc_health_article_main-content_article-body_6_552562\" href=\"https:\/\/www.foxnews.com\/category\/health\/vitamins-supplements\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">over-the-counter supplements<\/a>.<\/p>\n<p data-layout-index=\"5\">Because the study relied on laboratory cell cultures and animal models, the findings may not directly translate to how human patients process these supplements during treatment, the team noted.<\/p>\n<p> <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2026\/08\/hands-medicine-bottle-pill.jpg\" alt=\"Hands hold a medicine bottle and a pill.\" width=\"1200\" height=\"675\"\/> <\/p>\n<p>The findings indicate these supplements are not inherently dangerous for healthy individuals using them for general anti-aging or wellness, but pose serious risks when taken during active chemotherapy. (iStock)<\/p>\n<p data-layout-index=\"5\">Additionally, the research focused exclusively on pancreatic cancer, meaning the supplements may not have the same effect on chemotherapy for other cancer types or with different drug combinations.<\/p>\n<p data-layout-index=\"5\"><a href=\"https:\/\/foxnews.onelink.me\/xLDS?pid=AppArticleLink&amp;af_dp=foxnewsaf%3A%2F%2F&amp;af_web_dp=https%3A%2F%2Fwww.foxnews.com%2Fapps-products\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><strong>CLICK HERE TO DOWNLOAD THE FOX NEWS APP<\/strong><\/a><\/p>\n<p data-layout-index=\"5\">The study also only evaluated short-term cellular responses under controlled laboratory conditions and not human clinical trials, so it remains unclear how these supplements could affect cancer patients over time.<\/p>\n<p data-layout-index=\"5\">Fox News Digital reached out to multiple NAD+ supplement manufacturers for comment.<\/p>\n<p>Khloe Quill is a <a href=\"https:\/\/www.foxnews.com\/lifestyle\" target=\"_blank\" rel=\"nofollow noopener\">lifestyle<\/a> writer with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Pancreatic cancer vaccine shows promise in first human trial Family medicine physician Dr. Jessica Gray details a new&hellip;\n","protected":false},"author":2,"featured_media":654395,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[78],"tags":[110,2566,18,135,19,17,3521,4481,719,26332],"class_list":["post-654394","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-cancer","tag-cancer-research","tag-eire","tag-health","tag-ie","tag-ireland","tag-lifestyle","tag-medical-research","tag-medications","tag-vitamins-supplements"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/117152304034310095","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/654394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=654394"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/654394\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/654395"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=654394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=654394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=654394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}